6,640
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Best management of patients with an acute sore throat – a critical analysis of current evidence and a consensus of experts from different countries and traditions

ORCID Icon, , , , , & show all
Pages 384-395 | Received 05 Jan 2023, Accepted 13 Mar 2023, Published online: 27 Mar 2023

References

  • André M, Vernby Å, Odenholt I, et al. Diagnosis-prescribing surveys in 2000, 2002 and 2005 in Swedish general practice: consultations, diagnosis, diagnostics and treatment choices. Scand J Infect Dis. 2008;40(8):648–654.
  • Tyrstrup M, Beckman A, Molstad S, et al. Reduction in antibiotic prescribing for respiratory tract infections in Swedish primary care – a retrospective study of electronic patient records. BMC Infect Dis. 2016;16:709.
  • Armstrong GL, Pinner RW. Outpatient visits for infectious diseases in the United States, 1980 through 1996. Arch Intern Med. 1999;159(21):2531–2536.
  • Gunnarsson R, Orda U, Elliott B, et al. What is the optimal strategy for managing primary care patients with an uncomplicated acute sore throat? Comparing the consequences of nine different strategies using a compilation of previous studies. BMJ Open. 2022;12(4):e059069.
  • National Institute for Health and Care Excellence (NICE). NICE Guideline [NG84] – sore throat (acute): antimicrobial prescribing. 2018. Available from: https://www.nice.org.uk/guidance/ng84
  • Scottish Intercollegiate Guidelines Network (SIGN). SIGN Guideline [117] – management of sore throat and indications for tonsillectomy. A national clinical guideline. 2010. Available from: https://www.nice.org.uk/guidance/ng84
  • Shulman ST, Bisno AL, Clegg HW, et al. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis. 2012;55(10):1279–1282.
  • Pelucchi C, Grigoryan L, Galeone C, ESCMID Sore Throat Guideline Group, et al. Guideline for the management of acute sore throat. Clin Microbiol Infect. 2012;18(Suppl 1):1–28.
  • Hoare KJ, Ward E, Arroll B. International sore throat guidelines and international medical graduates: a mixed methods systematic review. J Prim Health Care. 2016;(1):20–29.
  • Mustafa Z, Ghaffari M. Diagnostic methods, clinical guidelines, and antibiotic treatment for group A streptococcal pharyngitis: a narrative review. Front Cell Infect Microbiol. 2020;10:563627.
  • Gunnarsson RK, Ebell M, Wächtler H, et al. The association between guidelines and medical practitioners’ perception of best management for patients attending with an apparently uncomplicated acute sore throat – a cross-sectional survey in five countries. BMJ Open. 2020;10(9):e037884.
  • Gunnarsson RK, Holm SE, Söderström M. The prevalence of beta-haemolytic streptococci in throat specimens from healthy children and adults. Implications for the clinical value of throat cultures. Scand J Prim Health Care. 1997;15(3):149–155.
  • Hedin K, Bieber L, Lindh M, et al. The aetiology of pharyngotonsillitis in adolescents and adults – Fusobacterium necrophorum is commonly found. Clin Microbiol Infect. 2015;21(3):263.e1–263.e7.
  • Gunnarsson RK, Manchal N. Group C beta haemolytic Streptococci as a potential pathogen in patients presenting with an uncomplicated acute sore throat – a systematic literature review and meta-analysis. Scand J Prim Health Care. 2020;38(2):226–237.
  • Lindbaek M, Hoiby EA, Lermark G, et al. Clinical symptoms and signs in sore throat patients with large colony variant β-haemolytic streptococci groups C or G versus group A. Br J Gen Pract. 2005;55(517):615–619.
  • Tiemstra J, Miranda RL. Role of non-group A streptococci in acute pharyngitis. J Am Board Fam Med. 2009;22(6):663–669.
  • Little P, Moore M, Hobbs FDR, PRISM investigators, et al. PRImary care Streptococcal Management (PRISM) study: identifying clinical variables associated with Lancefield group A β-haemolytic streptococci and Lancefield non-Group A streptococcal throat infections from two cohorts of patients presenting with an acute sore throat. BMJ Open. 2013;3(10):e003943.
  • Centor RM, Atkinson TP, Ratliff AE, et al. The clinical presentation of Fusobacterium-positive and streptococcal-positive pharyngitis in a university health clinic: a cross-sectional study. Ann Intern Med. 2015;162(4):241–247.
  • Woldan-Gradalska P, Gradalski W, Gunnarsson R, et al. Group A beta haemolytic streptococci as a pathogen in patients presenting with an uncomplicated acute sore throat – a systematic literature review and meta-analysis considering climate zone and patient’s age. (Submitted manuscript). 2022.
  • Klug TE, Rusan M, Fuursted K, et al. A systematic review of Fusobacterium necrophorum-positive acute tonsillitis: prevalence, methods of detection, patient characteristics, and the usefulness of the Centor score. Eur J Clin Microbiol Infect Dis. 2016;35(12):1903–1912.
  • Malmberg S, Petrén S, Gunnarsson R, et al. Acute sore throat and Fusobacterium necrophorum in primary health care – a systematic review and meta-analysis. BMJ Open. 2021;11(6):e042816.
  • Gunnarsson RK, Lanke J. The predictive value of microbiologic diagnostic tests if asymptomatic carriers are present. Stat Med. 2002;21:1773–1785.
  • Orda U, Gunnarsson RK, Orda S, et al. Etiologic predictive value of a rapid immunoassay for detection of group A streptococci antigen from throat swabs in patients presenting with a sore throat. North American Primary Care Research Group (NAPCRG) Annual Meeting; 2016 Nov 12–16; Colorado Springs, CO, USA. 2016. Available from: https://www.youtube.com/watch?v=YHMeQuKOYpw
  • Spinks A, Glasziou PP, Del Mar CB. Antibiotics for treatment of sore throat in children and adults. Cochrane Database Syst Rev. 2021;12(12):CD000023.
  • Nygren D, Wasserstrom L, Holm K, et al. Associations between findings of Fusobacterium necrophorum or β-hemolytic streptococci and complications in pharyngotonsillitis – a registry-based study in Southern Sweden. Clin Infect Dis. 2023;76(3):e1428–e1435.
  • Lemierre A. On certain septicaemias due to anaerobic organisms. Lancet. 1936;227(5874):701–703.
  • Fine AM, Nizet V, Mandl KD. Large-scale validation of the Centor and McIsaac scores to predict group A streptococcal pharyngitis. Arch Intern Med. 2012;172(11):847–852.
  • Centor RM, Witherspoon JM, Dalton HP, et al. The diagnosis of strep throat in adults in the emergency room. Med Decis Making. 1981;1(3):239–246.
  • McIsaac WJ, White D, Tannenbaum D, et al. A clinical score to reduce unnecessary antibiotic use in patients with sore throat. CMAJ. 1998;158(1):75–83.
  • McIsaac WJ, Goel V, To T, et al. The validity of a sore throat score in family practice. CMAJ. 2000;163(7):811–815.
  • Little P, Hobbs FD, Moore M, PRISM investigators, et al. Clinical score and rapid antigen detection test to guide antibiotic use for sore throats: randomised controlled trial of PRISM (primary care streptococcal management). BMJ. 2013;347:f5806.
  • Little P, Stuart B, Hobbs FD, DESCARTE investigators, et al. Predictors of suppurative complications for acute sore throat in primary care: prospective clinical cohort study. BMJ. 2013;347:f6867.
  • Watkins DA, Johnson CO, Colquhoun SM, et al. Global, regional, and national burden of rheumatic heart disease, 1990-2015. N Engl J Med. 2017;377(8):713–722.
  • Catanzaro FJ, Stetson CA, Morris AJ, et al. The role of the streptococcus in the pathogenesis of rheumatic fever. Am J med. 1954;17(6):749–756.
  • Lennon D, Anderson P, Kerdemilidis M, et al. First presentation acute rheumatic fever is preventable in a community setting: a school-based intervention. Pediatr Infect Dis J. 2017;36(12):1113–1118.
  • Robertson KA, Volmink JA, Mayosi BM. Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis. BMC Cardiovasc Disord. 2005;5(1):11.
  • Beaton A, Okello E, Rwebembera J, et al. Secondary antibiotic prophylaxis for latent rheumatic heart disease. N Engl J Med. 2022;386(3):230–240.
  • Kevat PM, Reeves BM, Ruben AR, et al. Adherence to secondary prophylaxis for acute rheumatic fever and rheumatic heart disease: a systematic review. Curr Cardiol Rev. 2017;13(2):155–166.
  • Kevat PM, Gunnarsson R, Reeves BM, et al. Adherence rates and risk factors for suboptimal adherence to secondary prophylaxis for rheumatic fever. J Paediatr Child Health. 2020;57(3):419–424.
  • Pichichero ME, Disney FA, Talpey WB, et al. Adverse and beneficial effects of immediate treatment of Group A beta-hemolytic streptococcal pharyngitis with penicillin. Pediatr Infect Dis J. 1987;6(7):635–643.
  • Nelson JD. The effect of penicillin therapy on the symptoms and signs of streptococcal pharyngitis. Pediatr Infect Dis. 1984;3(1):10–13.
  • Krober MS, Bass JW, Michels GN. Streptococcal pharyngitis. Placebo-controlled double-blind evaluation of clinical response to penicillin therapy. JAMA. 1985;253(9):1271–1274.
  • Zwart S, Rovers MM, de Melker RA, et al. Penicillin for acute sore throat in children: randomised, double blind trial. BMJ. 2003;327(7427):1324.
  • De Meyere M, Mervielde Y, Verschraegen G, et al. Effect of penicillin on the clinical course of streptococcal pharyngitis in general practice. Eur J Clin Pharmacol. 1992;43(6):581–585.
  • Middleton DB, D'Amico F, Merenstein JH. Standardized symptomatic treatment versus penicillin as initial therapy for streptococcal pharyngitis. J Pediatr. 1988;113(6):1089–1094.
  • Dagnelie CF, van der Graaf Y, De Melker RD. Do patients with sore throat benefit from penicillin? A randomized double-blind placebo-controlled clinical trial with penicillin V in general practice. Br J Gen Pract. 1996;46(411):589–593.
  • Petersen K, Phillips RS, Soukup J, et al. The effect of erythromycin on resolution of symptoms among adults with pharyngitis not caused by group A streptococcus. J Gen Intern Med. 1997;12(2):95–101.
  • Zwart S, Sachs AP, Ruijs GJ, et al. Penicillin for acute sore throat: randomised double blind trial of seven days versus three days treatment or placebo in adults. BMJ. 2000;320(7228):150–154.
  • Bank S, Christensen K, Kristensen LH, et al. A cost-effectiveness analysis of identifying Fusobacterium necrophorum in throat swabs followed by antibiotic treatment to reduce the incidence of Lemierre’s syndrome and peritonsillar abscesses. Eur J Clin Microbiol Infect Dis. 2013;32(1):71–78.
  • Seeley A, Fanshawe T, Voysey M, et al. Diagnostic accuracy of Fever-PAIN and Centor criteria for bacterial throat infection in adults with sore throat: a secondary analysis of a randomised controlled trial. BJGP Open. 2021;5(6):20211214.
  • Willis BH, Coomar D, Baragilly M. Comparison of Centor and McIsaac scores in primary care: a meta-analysis over multiple thresholds. Br J Gen Pract. 2020;70(693):e245–e254.
  • Cheung L, Pattni V, Peacock P, et al. Throat swabs have no influence on the management of patients with sore throats. J Laryngol Otol. 2017;131(11):977–981.
  • Orda U, Biswadev M, Orda S, et al. Point of care testing for group A streptococci in patients presenting with pharyngitis will improve appropriate antibiotic prescription. Emerg Med Australas. 2016;28(2):199–204.
  • Orda U, Gunnarsson RK, Orda S, et al. Etiologic predictive value of a rapid immunoassay for detection of group A streptococci antigen from throat swabs on patients presenting with a sore throat. Int J Infect Dis. 2016;45:32–35.
  • Gunnarsson MS, Sundvall PD, Gunnarsson R. In primary health care, never prescribe antibiotics to patients suspected of having an uncomplicated sore throat caused by group A beta-haemolytic streptococci without first confirming the presence of this bacterium. Scand J Infect Dis. 2012;44(12):915–921.
  • Kenealy T. Sore throat. BMJ Clin Evid. 2007;2007:1509.
  • Mantzourani E, Wasag D, Cannings-John R, et al. Characteristics of the sore throat test and treat service in community pharmacies (STREP) in Wales: cross-sectional analysis of 11 304 consultations using anonymized electronic pharmacy records. J Antimicrob Chemother. 2022;78(1):84–92.
  • Cohen JF, Pauchard JY, Hjelm N, et al. Efficacy and safety of rapid tests to guide antibiotic prescriptions for sore throat. Cochrane Database Syst Rev. 2020;6(6):CD012431.
  • Gunnarsson RK, Orda U, Elliott B, et al. Improving antibiotics targeting using PCR point-of-care testing for group A streptococci in patients with uncomplicated acute sore throat. Aust J Gen Pract. 2021;50(1–2):745–753.
  • Fraser H, Gallacher D, Achana F, et al. Rapid antigen detection and molecular tests for group A streptococcal infections for acute sore throat: systematic reviews and economic evaluation. Health Technol Assess. 2020;24(31):1–232.
  • Health Technology Wales (HTW). Rapid antigen detection tests for group A streptococcal infections to treat people with a sore throat in the community pharmacy setting (Evidence Appraisal Report). 2020; p. 20. Available from: https://healthtechnology.wales/wp-content/uploads/2020/02/EAR020-Rapid-antigen-detecting-tests.pdf
  • Health Technology Wales (HTW). Rapid antigen detection tests for group A streptococcal infections to treat people with a sore throat in the community pharmacy setting (HTW Guidance). 2020; p. 24. Available from: https://healthtechnology.wales/wp-content/uploads/2020/10/GUI020-Rapid-antigen-detecting-tests-English.pdf
  • Klepser DG, Bisanz SE, Klepser ME. Cost-effectiveness of pharmacist-provided treatment of adult pharyngitis. Am J Manag Care. 2012;18(4):e145–e154.
  • Andre M, Hedin K, Hakansson A, et al. More physician consultations and antibiotic prescriptions in families with high concern about infectious illness-adequate response to infection-prone child or self-fulfilling prophecy? Fam Pract. 2007;24(4):302–307.
  • OECD iLibrary. Health at a Glance: Europe 2020. State of health in the EU cycle. Paris: OECD Publishing; 2020.
  • Tyrstrup M, van der Velden A, Engstrom S, et al. Antibiotic prescribing in relation to diagnoses and consultation rates in Belgium, The Netherlands and Sweden: use of European quality indicators. Scand J Prim Health Care. 2017;35(1):10–18.
  • Pitts J, Vincent S. What influences doctors’ prescribing? Sore throats revisited. J R Coll Gen Pract. 1989;39(319):65–66.
  • Howie JG. Some non-bacteriological determinants and implications of antibiotic use in upper respiratory tract illness. Scand J Infect Dis Suppl. 1983;39:68–72.
  • Coxeter P, Del Mar CB, McGregor L, et al. Interventions to facilitate shared decision making to address antibiotic use for acute respiratory infections in primary care. Cochrane Database Syst Rev. 2015;2015(11):CD010907.
  • Little P, Moore M, Kelly J, PIPS Investigators, et al. Delayed antibiotic prescribing strategies for respiratory tract infections in primary care: pragmatic, factorial, randomised controlled trial. BMJ. 2014;348:g1606.